lenalidomide has been researched along with Erythema in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Katayama, S; Ota, M; Yamaga, M | 1 |
| Eikenberg, JD; Grider, DJ; Patel, RT; Phillips, MA; Quan, EY | 1 |
| Fabbro, SK; Kaffenberger, BH | 1 |
| Giorgadze, T; Tageja, N; Zonder, J | 1 |
4 other study(ies) available for lenalidomide and Erythema
| Article | Year |
|---|---|
Fever, Pancytopenia, and Tender Erythematous Plaques in a Patient With Multiple Myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Erythema; Humans; Lenalidomide; Multiple Myeloma; Neoplasm Recurrence, Local; Pancytopenia; Thalidomide | 2023 |
Lenalidomide-induced symmetrical drug-related intertriginous and flexural exanthema.
Topics: Drug Eruptions; Erythema; Exanthema; Humans; Lenalidomide; Skin | 2023 |
Resident rounds part III: plasma cell leukemia with initial cutaneous presentation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Examination; Bortezomib; Dexamethasone; Doxorubicin; Erythema; Fatal Outcome; Female; Humans; Lenalidomide; Leukemia, Plasma Cell; Middle Aged; Renal Dialysis; Thalidomide; Vincristine | 2014 |
Dermatological complications following initiation of lenalidomide in a patient with chronic lymphocytic leukaemia.
Topics: Erythema; Female; Humans; Lenalidomide; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Sweet Syndrome; Thalidomide | 2011 |